Skip to content. | Skip to navigation

Personal tools
Log in


You are here: Home / About / News Releases / Government of Canada Strengthens Cancer Research in British Columbia

Government of Canada Strengthens Cancer Research in British Columbia

$2.2 million in federal funding announced at the Michael Smith Genome Sciences Centre for the BC Cancer Agency, in order to purchase three leading-edge genome sequencers .

The Honourable James Moore, Minister of Canadian Heritage and MP for Port Moody–Westwood–Port Coquitlam;

Tim Manning, Board of Directors, Provincial Health Services Authority; Brendan Robinson, VP Development, BC Cancer

Foundation; Dr. Samuel Abraham, VP Research, BC Cancer Agency

October 07, 2011                   Vancouver, British Columbia

Cancer research in British Columbia received a significant boost today, thanks to nearly $2.2 million in federal funding announced for the BC Cancer Agency.

Our Government is focused on the economic recovery and we believe that science, technology and innovation are vital to both supporting economic competitiveness and growth, and a healthy society, said the Honourable James Moore, Member of Parliament for Port Moody–Westwood–Port Coquitlam and Minister of Canadian Heritage and Official Languages, on behalf of the Honourable Lynne Yelich, Minister of State for Western Economic Diversification. We are pleased that our funding will help ensure the BC Cancer Agency and our local industry maintain their prominence as leaders in cancer research.

With Western Economic Diversification Canada (WD) funding, the BC Cancer Agency will purchase three leading-edge genome sequencers to be installed at its internationally recognized Canada’s Michael Smith Genome Sciences Centre(GSC). As well, a new business outreach coordinator will work to increase the centre's linkages with industry.

This combination will help the GSC win large-scale research projects, make sequencing more affordable for local industry and the broader life sciences community, while helping retain and attract leading researchers whose work in genome sequencing will enable ongoing cancer research.

This funding from Western Economic Diversification Canada and the BC Cancer Foundation will provide researchers at the BC Cancer Agency’s Genome Sciences Centre new sequencing technology that is vital for continuing to harness the power of genomics research. Working toward providing new solutions for the challenges in cancer research has become more attainable, said Dr. Samuel Abraham, Vice President of Research, BC Cancer Agency.

The GSC is one of fifteen research programs that operate as part of the BC Cancer Agency. Over the past decade, the GSC has become a cornerstone of the important life sciences sector, the largest Canadian sequencing facility and a world leader in cancer genomics and research, bioinformatics, and technology development.

Thanks to the support of BC Cancer Foundation donors and Western Economic Diversification Canada we are proud to be a part of this significant acquisition of potentially life-saving technology. says Brendan Robinson, Vice President of Development of the BC Cancer Foundation. This investment into state-of-the-art sequencing technology at the BC Cancer Agency’s Genome Sciences Centre is fantastic news for the 23,000 British Columbians who will be diagnosed with cancer this year, their families and clinicians as we boost the GSC’s capacity to make personalized medicine a reality for cancer care in B.C.

Western Economic Diversification Canada works with the provinces, industry associations and communities to promote the development and diversification of the western economy, coordinates federal economic activities in the West and advances the interests of western Canadians in national decision making.

For additional information, contact:

Media inquiries:

Lubna Ekramoddoullah
Senior Public Affairs Officer
Phone: 604-675-7459

Corporate communications:

Cher Sawchuk
Communications Leader
Phone: 604-675-8258

Page last modified Oct 07, 2011